21 Recruiting Studies Using Dacarbazine
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Dacarbazine
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
Classical Hodgkin Lymphoma
View Study & Checklist ➔Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Stage II Childhood Hodgkin Lymphoma
View Study & Checklist ➔Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Ann Arbor Stage I Hodgkin Lymphoma
View Study & Checklist ➔Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
📍 Children's Hospital of Alabama ( Site 0023) — Birmingham, Alabama
Hodgkin Lymphoma
View Study & Checklist ➔PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Hodgkin Lymphoma
View Study & Checklist ➔A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
📍 Children's Hospital Colorado — Aurora, Colorado
Hodgkin Disease
View Study & Checklist ➔IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
📍 Honor Health — Scottsdale, Arizona
Metastatic Uveal Melanoma
View Study & Checklist ➔A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
📍 Karmanos Cancer Institute — Detroit, Michigan
Hodgkin Lymphoma
View Study & Checklist ➔Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ann Arbor Stage III Hodgkin Lymphoma
View Study & Checklist ➔A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
📍 Mayo Clinic - Arizona — Phoenix, Arizona
Advanced or Metastatic NRAS-mutant Melanoma
View Study & Checklist ➔Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma
📍 Stanford Cancer Center — Stanford, California
Classic Hodgkin Lymphoma
View Study & Checklist ➔Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Ann Arbor Stage I Hodgkin Lymphoma
View Study & Checklist ➔SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
📍 Mayo Clinic — Phoenix, Arizona
Melanoma, Cutaneous Malignant
View Study & Checklist ➔Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
📍 Mayo Clinic Arizona — Phoenix, Arizona
Alveolar Soft Part Sarcoma
View Study & Checklist ➔A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
📍 Children's Hospital of Alabama — Birmingham, Alabama
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
View Study & Checklist ➔A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
Hodgkin Lymphoma
View Study & Checklist ➔Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment
📍 City of Hope Medical Center — Duarte, California
Classic Hodgkin Lymphoma
View Study & Checklist ➔Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
📍 Stanford University - (Stanford Cancer Institute) — Stanford, California
Hodgkin Lymphoma
View Study & Checklist ➔BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
Hodgkin Lymphoma
View Study & Checklist ➔Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma
📍 City of Hope — Irvine, California
Advanced Hodgkin Lymphoma
View Study & Checklist ➔Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
📍 UT MD Anderson — Houston, Texas
Hodgkin Lymphoma
View Study & Checklist ➔